NASDAQ:RMTI
Rockwell Medical, Inc.
Rockwell Medical, Inc.'s revenue fell 31.8% in fiscal 2025 to $69.3M while operating margin fell to −6.8%. Free cash flow was −$1.2M, −1.7% of revenue, and the diluted share count rose 15.8%.Summary generated from Rockwell Medical, Inc.'s SEC filings. Latest annual report filed Mar 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$69.3M
Revenue growth−31.8%
Revenue, 5-yr CAGR+2.2%
Gross margin16.9%
Operating margin−6.8%
Net margin−7.7%
ROIC−12.3%
Return on equity−15.3%
Debt / equity0.24
Free cash flow−$1.2M
FCF margin−1.7%
Share count change+15.8%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 62 | 73 | 84 | 101 | 69 |
| Operating income | −30 | −17 | −7 | 1 | −5 |
| Net income | −33 | −19 | −8 | −0 | −5 |
| Free cash flow | n/a | n/a | −10 | 3 | −1 |
Recent filings
- 4Insider transaction report
Oct 5, 2026 - 8-KRegulation FD disclosure
Aug 13, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026 - 8-KResults of operations and financial condition
Aug 13, 2026 - 8-KOther events
Jul 20, 2026 - 4Insider transaction report
Jul 6, 2026 - 8-KAmendment to articles or bylaws
Jun 29, 2026 - 8-KResults of a shareholder vote
Jun 15, 2026